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Background. It has been observed that African American race is associated with a lower prevalence of atrial ﬁbrillation (AF)
compared to Caucasian race. To better quantify the association between African American race and AF, we performed a meta-
analysis of published studies among diﬀerent patient populations which reported the presence of AF by race. Methods.Al i t e r a t u r e
search was conducted using electronic databases between January 1999 and January 2011. The search was limited to published
studies in English conducted in the United States, which clearly deﬁned the presence of AF in African American and Caucasian
subjects. A meta-analysis was performed with prevalence of AF as the primary endpoint. Results. In total, 10 studies involving
1,031,351 subjects were included. According to a random eﬀects analysis, African American race was associated with a protective
eﬀect with regard to AF as compared to Caucasian race (odds ratio 0.51, 95% CI 0.44 to 0.59, P<0.001). In subgroup analyses,
African American race was signiﬁcantly associated with a lower prevalence of AF in the general population, those hospitalized
or greater than 60 years old, postcoronary artery bypass surgery patients, and subjects with heart failure. Conclusions.I nab r o a d
sweep of subjects in the general population and hospitalized patients, the prevalence of AF in African Americans is consistently
lower than in Caucasians.
1.Introduction
Atrialﬁbrillation(AF)isthemostcommontypeofpersistent
arrhythmia in the United States, with prevalence likely to
rise and a burgeoning national healthcare cost burden [1].
Despite its familiarity, the well-known associated risk factors
such as advancing age, hypertension [2], heart failure [3],
diabetes [4], and larger body mass index [5]f a i lt of u l l y
account for the burden of risk leading to AF [6]. Recently,
race and related genetic variants have been suggested as
novel susceptibility factors contributing to the development
of AF [7]. Along these lines, it has been observed that
African American race confers a lower risk of developing AF
compared to white race despite having a greater risk burden
for AF [8, 9]. Although these epidemiologic ﬁndings seem
consistent, a counterpoint contends that an underdiagnosis
of AF among diﬀerent racial groups may be the contributing
factor to account for the AF disparity seen in African
Americans [10]. Investigators have questioned the impact of
race on the epidemiology of AF based on issues relating to
the imperfect methodology for AF detection, coupled with
the suspicion that AF is unequally diagnosed among racial
groups [10, 11].
The aim of the present study was to systematically
quantify the association between African American race and
prevalence of AF in a wide range of patient populations. To
address this objective, we performed a meta-analysis of avail-
able published studies among diﬀerent patient subgroups
which addressed the presence of AF in subjects of African
American and Caucasian race.2 Cardiology Research and Practice
2. Methods
2.1. Search Strategy. A detailed literature search was con-
ducted using electronic databases, including PubMed, MD
Consult, and ISI Web of Science for the period between
1999 and January 2011. All designs of studies (observational,
cross-sectional, case-control, and cohort studies) on the
epidemiology of AF were considered. The following search
terms were used: atrial ﬁbrillation, blacks, African American,
African continental ancestry group, race, ethnicity, and preva-
lence. Combinations of these keywords or search terms were
used to expand the sample size for the analysis; the search
strategy for PubMed is shown in the appendix. The search
was limited to studies published in the English language and
conducted in the United States. For all initially retrieved
studies,studyabstractswerereviewedandscreened,followed
by full-text article review and appraisal for eligibility. A
manualsearchofreferencecitationsfromtheselectedstudies
was also considered for inclusion. If multiple articles were
published for a single study, the latest publication was
selected. Studies were appraised and selected by 2 reviewers
(G.M.N., M.B.H.). Disagreements on inclusion/exclusion
were solved by consensus or by consultation with a third
reviewer (C.R.A.).
2.2. Study Criteria. Included studies must have deﬁned AF
as AF or atrial ﬂutter found in more than one outpatient
diagnosis of AF, more than 1 electrocardiogram with AF,
more than 1 hospitalization for AF, or more than 1 electro-
cardiogram with AF in hospital after cardiac surgery. The
studies must have clearly deﬁned African Americans or non-
Hispanic blacks and Caucasians or non-Hispanic whites (as
members of one racial group in the United States, resp.),
and reported their AF and non-AF cases in each group. This
allowed for data from the various studies to be merged. The
studies must also have included consecutive (nonselected)
samples, with strong external validity relative to the speciﬁc
study question. Exclusion criteria for the studies included
studypopulation<150patients;singlegenderstudies;studies
which compared blacks to other groups or whites to other
groups, but not whites to blacks speciﬁcally; studies which
focused on patients with stroke; studies which did not focus
on epidemiological associations but rather were aimed at
answering a speciﬁc clinical question. The majority of these
studies were eliminated because of sampling techniques,
which though necessary for clinical research, introduce
sampling bias into epidemiological analysis.
2.3.DataExtraction. Thefollowingdatawereextractedfrom
the original studies: (1) characteristics of study and study
subjects (age range inclusion, type of study population,
method of AF ascertainment, and states where subjects
were enrolled), (2) sample sizes, (3) number of African
Americans with AF, (4) number of African Americans
without AF, (5) number of Caucasians with AF, and (6)
number of Caucasians without AF. Study diﬀerences as to
collection or report of data were noted when appropriate.
Two investigators (G.M.N., M.B.H.) reviewed and extracted
the data from the included studies.
2.4. Study Quality Assessment. We systematically assessed
key points of study quality proposed by the MOOSE
collaboration [12]. These key points were (1) clear identiﬁ-
cation of study population; (2) clear deﬁnition of outcome
and outcome assessment; (3) independent assessment of
outcome parameters (i.e., ascertainment of outcomes done
by researchers other than the ones involved in the study); (4)
noselectivelossduringfollowup;(5)important confounders
and/or prognostic factors identiﬁed. Each point was rated as
Yes/No. If the description was unclear, we considered this as
“No”.
2.5. Statistical Analysis. Our study followed the Preferred
Reporting Items for Systematic Reviews and Meta-analyses
(PRISMA) statement [13]. The association between race
and AF was shown as odds ratios (OR) and their 95%
conﬁdence intervals (CI). ORs were reported as adjusted
for confounders when available. When incidence rates were
reported, prevalence rates were calculated in order to be
consistent with other included studies. Prevalence was
estimated by dividing the number of total AF in each race
by the corresponding number of total individuals within that
cohort.A DerSimonian andLaird random eﬀectsmodel[14]
wasusedduetotheexpectedheterogeneityacrossstudies;the
inverse variance method was used to calculate pooled ORs.
StatisticalheterogeneitywasevaluatedwiththeCochranChi-
square (χ2) and quantiﬁed with the I2 statistic (low is <25%,
moderate25–50%,high>50%)[15].Subgroupanalyseswere
prespeciﬁed to deal with heterogeneity and were considered
secondaryanalyses.Subgroupsweredeﬁnedasgeneralpublic
age >50 years; hospitalized or elderly; postcoronary artery
bypass grafting surgery; heart failure. Publication bias was
evaluated by testing for funnel plot asymmetry and the
Egger’s regression test. Signiﬁcance was set at a P value of
less than 0.05. All statistical calculations were made using
Medcalc 2011 software (Mariakerke, Belgium), the RevMan
5.1software(CochraneCollaboration,London,UK),andthe
metafor p a c k a g eo fR( http://www.metafor-project.org/).
3. Results
After an initial search identiﬁed 488 studies, application of
inclusionandexclusioncriteriaselected10studies[7,16–24]
with a total of 1,031,351 subjects determined to be suitable
forthemeta-analysis(Figure 1).Mostoftheexcludedstudies
were based on absence to address AF prevalence. Further,
many of the studies which addressed AF prevalence did not
report race-speciﬁc data. The number of subjects by race
involved in the studies ranged from 50 to 519,714. Of the
10 identiﬁed studies, 4 studies with 812,200 subjects were
conducted in the general population [7, 16, 17, 22], 2 studies
with 1,536 subjects in patients with heart failure [18, 19],
1 with 211,915 subjects in patients on hemodialysis [20], 1
with 2,123 subjects in hospitalized patients [21], and 2 with
3,577subjectsinpatientspostcoronaryarterybypassgrafting
surgery [23, 24]. The characteristics of the 10 studies are
shown in Table 1.Cardiology Research and Practice 3
Table 1: Characteristics of included studies in the meta-analysis.
First Author
Year (Ref) Study Years AA, n Caucasian, n Age, yrs Population Study design Enrollment
states
Marcus et al. 2010
[7] 1989-1999 804 4,543 >65 Older
population Cohort
15 U.S.
states∗∗,
Washington
D.C.
Go et al. 2001
[16] 1996-1997 39,579 519,714 >50∗ General
population Cross-sectional California
Alonso et al. 2009
[17] 1987–2004 4,115 11,292 >55∗ General
population Cohort Maryland,
Minnesota,
Mississippi,
N. Carolina
Afzal et al.
1999 [18] 1996 113 50 >35∗ Heart failure Cohort Michigan
Ruo et al.
2004 [19] 1999-2000 223 1,150 >35∗ Heart failure Cohort California
Winkelmayer
et al. 2011 [20] 1992–2006 90,217 121,698 >30∗ Hemodialysis Cohort United States
Upshaw Jr.
2002 [21] 1996–1998 922 1,201 >20 Hospitalized
patients Cohort Georgia
Shen et al.
2010 [22] 2008 40,293 191,860 >60 Older
population Cross-sectional California
Smith et al.
2006 [23] 1993–2005 644 1,932 >25∗ Post-CABG Case control Ohio
Lahiri et al. 2011
[24] 2004–2008 270 731 >25∗ Post-CABG Cohort Michigan
∗More than 99% of patients were older than the stated age, according to reported study demographics. It should be noted that in patients less than 50 years
of age, the prevalence of AF was similar across racial lines in the general population.
∗∗StatesincludedAlabama,California,Connecticut,Florida,Georgia,Illinois,Iowa,Maryland,Minnesota,NorthCarolina,Oregon,Pennsylvania,Tennessee,
Texas, and Washington.
AA = African American; CABG = coronary artery bypass grafting.
The study by Go et al. [16] had a sample which included
persons other than Caucasians and African Americans which
were eliminated from the meta-analysis. Further, as there
was limited data on race for those <50 years old and given
the very low prevalence of AF in younger patients, the
analyzedpatientswerethose>50yearsold(A.S.Go,personal
communication, April 26, 2011). It should also be noted that
the Go et al. [16] study failed to show diﬀerences in AF
prevalence among patients 50–59 years of age. In the study
by Alonso et al. [17], incidence rates were reported. Based
on the study data, prevalence rates were calculated in order
to be consistent with other included studies. In addition
to reporting data on hemodialysis patients, the report by
Winkelmayer et al. [20] noted that white race compared
to black race was found to be an independent predictor of
AF in the nondialysis chronic kidney disease population. In
the study by Marcus et al. [7], we used only the data from
the Cardiovascular Health Study (CHS) cohort, as they also
included the Atherosclerosis Riskin Communities study [17]
as part of their meta-analysis. Most of the studies had an
overall good quality (Table 2).
3.1. Meta-Analysis. All 10 studies reported a substantially
lower prevalence of AF among African Americans, as com-
pared to Caucasians (Figure 2, Table 3). African American
race was signiﬁcantly associated with a lower prevalence of
AF, as compared to Caucasian race (OR 0.51, 95% CI 0.44
to 0.59, P<0.001). Heterogeneity of the eﬀect measures
was high (Cochran’s Q = 147.3, P<0.001, I2 = 94%).
The association was similar when using the Risk Ratio (RR)
as a measure of association (RR 0.56, 95% CI 0.49 to
0.63). The subgroup analyses are summarized in Table 4.W e
notedthatAfricanAmericanracewassigniﬁcantlyassociated
with a lower prevalence of AF in the general public, those
hospitalized or elderly, patients postcoronary artery bypass
surgery, and subjects with heart failure. There was no
evidence of publication bias (Figure 3;E g g e r ’ st e s tP = 0.3).4 Cardiology Research and Practice
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Figure 1: PRISMA ﬂow diagram for selection of studies.
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Figure 2: Meta-analysis of the association between African American race and prevalence of atrial ﬁbrillation. The squares represent the
odds ratio and their sizes are proportional to the study sample; the horizontal lines represent 95% conﬁdence intervals (CI).Cardiology Research and Practice 5
Table 2: Study quality summary.
First author (Ref)
Clear
identiﬁcation of
study
population
Clear deﬁnition
of outcome and
outcome
assessment
Independent
Assessment of
outcome parameters
No selective loss
during followup
Important
confounders and/or
prognostic factors
indentiﬁed
Adjusted
odds ratio
(speciﬁc
adjusters)
Marcus et al. [7] Yes Yes Yes Yes Yes 0.75
(age, gender)
Go et al. [16] Yes Yes Yes Yes Yes Not provided
Alonso et al. [17] Yes Yes Yes Yes Yes 0.59
(age, gender)
Afzal et al. [18] Yes Yes No Yes Yes Not provided
Ruo et al. [19] Yes Yes Yes Yes Yes
0.51
(age, gender,
Comorbid
conditions,
medications)
Winkelmayer et al.
[20] Yes Yes Yes Yes Yes Not provided
Upshaw Jr. [21] Yes Yes Yes Yes Yes Not provided
Shen et al. [22] Yes Yes Yes Yes Yes 0.49
(age, gender)
Smith et al. [23] Yes Yes Yes Yes Yes 0.64
(unclear)
Lahiri et al. [24] Yes Yes Yes Yes Yes
0.54
(age, gender,
comorbid
conditions)
Table 3: Prevalence of atrial ﬁbrillation among African American and Caucasians in included studies.
First Author (Ref. #) Year AA with AF (%) Caucasian with AF (%)
Marcus et al. [7] 2010 120/804 15% 1052/4,543 23%
Go et al. [16] 2001 677/39,579 1.7% 13,054/519,714 2.5%
Alonso et al. [17] 2009 196/4,115 4.8% 889/11,292 7.9%
Afzal et al. [18] 1999 24/113 21% 21/50 42%
Ruo et al. [19] 2004 44/223 20% 440/1,150 38%
Winkelmayer et al. [20] 2011 5,859/90,217 6.5% 17,103/121,698 14%
Upshaw Jr. [21] 2002 23/922 2.5% 94/1,201 7.8%
Shen et al. [22] 2010 1,531/40,293 3.8% 15,349/191,860 8.0%
Smith et al. [23] 2006 111/644 17% 464/1,932 24%
Lahiri et al. [24] 2011 50/270 19% 214/731 29%
AA = African American; AF = atrial ﬁbrillation.
4. Discussion
In this meta-analysis involving over a million individuals, we
haveobservedconsistentlythatAfricanAmericansmanifesta
signiﬁcantlylowerprevalenceofAFcomparedtoCaucasians.
In fact, African American race appears protective of AF with
about a 50% decrease in risk compared to Caucasian race.
Our analysis goes on to demonstrate that the lower risk
of AF among African Americans was seen among various
patient subgroups such as the general public, hospitalized
patients, those with heart failure, and those postcoronary
artery bypass surgery.
With regard to the racial risk associated with AF,
it is suggested that the biologic underpinnings for the
observeddisparity inAFprevalencearegeneticallymediated.
Using ancestry informative markers, Marcus et al. observed
that increasing European ancestry, as opposed to African
ancestry, among African Americans was associated with an
increased risk of AF [7]. This ﬁnding was at odds with
the greater AF risk factor burden found among African
Americans, suggesting a rather dominant eﬀect of the racial-
genetic inﬂuence. Further insight into the race-mediated
eﬀects of AF risk comes from data on left atrial size.
Echocardiographiccohortstudieshavenotedlargerleftatrial
sizes in Caucasians as compared to African Americans even
after adjusting for signiﬁcant confounders [25]. In a study of
hypertensive males, whites had a greater left atrial size than
African Americans, even after adjustments for covariates6 Cardiology Research and Practice
Table 4: Subpopulation analysis showing the eﬀect of African American race on prevalence of atrial ﬁbrillation.
Subpopulation (Ref. #) AA AF% Caucasian AF% Sample size OR (95% CI) P value
Age > 50 years [16, 17] 2.0% 2.6% 574,700 0.66 (0.61–0.71) <0.001
Hospitalized or elderly [7, 21, 22]∗ 3.9% 8.4% 239,623 0.46 (0.36–0.59) <0.001
Post-CABG surgery [23, 24] 18% 25% 3,577 0.62 (0.52–0.76) <0.001
Heart failure [18, 19] 20% 38% 1,536 0.39 (0.29–0.54) <0.001
∗Utilized the Mantel-Haenszel method, carrying out a random eﬀects model, given that the test for heterogeneity is statistically signiﬁcant; Q = 8.7242; DF =
2; I2 = 77.1%; P = 0.0128. AA = AfricanAmerican;AF = atrial ﬁbrillation; CABG = coronary artery bypass grafting; CI = conﬁdence interval; OR = odds ratio.
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Figure 3: Funnel plot.
such as age, body mass index, and left ventricular mass [26].
The authors purported that conceivably, among blacks, an
increase in left atrial wall thickness may limit enlargement of
the left atrium, a hypothesis which requires testing.
A contrary perspective put forth to explain the lower
prevalence of AF among African Americans relative to
Caucasians is the existence of an ascertainment bias [10].
This hypothesis suggests that the ability to detect AF may
be diﬀerent across racial groups [10, 11]. It may be that
by applying more sensitive methods for AF detection, the
racial disparity would be attenuated [11]. It is also plausible
to consider that African Americans do not present similarly
with AF symptoms or do not access medical care equally
often. However, the inclusion of studies in this meta-analysis
that assessed serial electrocardiograms and hospitalized
patients on continuous electrocardiographic monitoring
such as those with post-operative AF after coronary bypass
surgery make the likelihood of ascertainment bias much less
likely. Furthermore, it has been suggested that the higher
stroke rate seen in African Americans is incompatible with
an apparent lower prevalence of AF. This viewpoint is not
supported by the ﬁnding of many studies that demonstrate
that African Americans with stroke, compared to whites,
are more often hypertensive and have a very low etiological
fraction of AF [27].
Our study has several limitations which are worthy of
mention. Since we did not have access to patient level
data, our analysis relied on published unadjusted aggregate
results. While some studies did not speciﬁcally report the
number of positive and negative cases, we had to calculate
the number based on reported incidence or prevalence
rates and general study population demographics. Despite
heterogeneity between the included studies, the odds ratios
reported were fairly consistent between studies. Indeed, we
feel that the use of random eﬀects model in our analysis
adequately accounts for the AF prevalence rate diﬀerence
between Caucasians and African Americans across a diverse
population. In this regard, the limited availability to expand
the subgroup populations, despite being a prespeciﬁed
analysis, represents a study shortcoming. Finally, it should
be recognized that although the meta-analysis was limited to
studies conducted in the United States, it remains possible
that a portion of African American subjects may be of
European or Caribbean descent, rendering the group more
geneticallydiverse.SimilarlywelimitedtheCaucasiangroups
towhitesofnon-Hispanicethnicityinaneﬀorttorestrictthe
comparison to a more homogeneous racial-ethnic group.
5. Conclusions
In our meta-analysis of a broad sweep of subjects in the
general population and hospitalized patients with various
cardiac and noncardiac conditions, the prevalence of AF in
African Americans is consistently lower than Caucasians.
Although explanations for this ﬁnding are only speculative,
they do suggest that despite a higher risk burden in African
Americans, a genetically mediated protective eﬀect may be
contributory.
Appendix
PubMed Search Strategy
(“atrial ﬁbrillation” [MeSH Terms] OR (“atrial” [All Fields]
AND “ﬁbrillation” [All Fields]) OR “atrial ﬁbrillation”
[All Fields]) AND ((“african continental ancestry group”
[MeSHTerms]OR(“African”[AllFields]AND“continental”
[All Fields] AND “ancestry” [All Fields] AND “group”
[All Fields]) OR “african continental ancestry group” [All
Fields] OR “blacks” [All Fields]) OR (“african americans”
[MeSH Terms] OR (“african” [All Fields] AND “ameri-
cans” [All Fields]) OR “african americans” [All Fields] OR
(“african” [All Fields] AND “american” [All Fields]) OR
“africanamerican”[AllFields])OR(“continentalpopulation
groups” [MeSH Terms] OR (“continental” [All Fields] AND
“population” [All Fields] AND “groups” [All Fields]) OR
“continental population groups” [All Fields] OR “race” [All
Fields]) OR (“ethnology” [Subheading] OR “ethnology”Cardiology Research and Practice 7
[All Fields] OR “ethnicity” [All Fields] OR “ethnology”
[MeSH Terms] OR “ethnicity” [All Fields] OR “ethnic
groups”[MeSH Terms] OR (“ethnic” [All Fields] AND
“groups” [All Fields]) OR “ethnic groups” [All Fields]))
AND (“epidemiology” [Subheading] OR “epidemiology”
[All Fields] OR “prevalence” [All Fields] OR “prevalence”
[MeSH Terms]).
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